Skip to content

IQVIA IQV Long-term debt, gross

Long-term debt, gross at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$32.25B+26.3%
Enterprise value$46.37B+18.6%
P/E23.3×+2.6×
P/S1.9×+0.3×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentCarryingAmount.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's long-term debt, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's long-term debt, gross?
IQVIA (IQV) reported long-term debt, gross of $15.91B in Q1 2026.
How has IQVIA's long-term debt, gross changed year-over-year?
IQVIA's long-term debt, gross increased by 10.6% year-over-year, from $14.39B to $15.91B.
What is the long-term trend for IQVIA's long-term debt, gross?
Over 5 years (2020 to 2025), IQVIA's long-term debt, gross has grown at a 4.6% compound annual growth rate (CAGR), from $12.6B to $15.8B.